Thorell Marella insider trades
Thorell Marella has filed 21 Form 4s with the SEC that we hold, for EVLO (Chief Financial Officer), Seres Therapeutics, Inc. (MCRB) (See Remarks), EPIX (Director) and GRI Bio, Inc. (VLON) (Director), among 6 companies in all. Across all of them we count 0 purchases worth $0 and 4 sales worth $26.0K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 2,004 shares of EVLO worth $19.1K, dated 2023-08-08. The first filing on our record is dated 2022-02-03 and the latest 2026-07-10.
EVLO
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-05-08 | S, sale reported on Form 4 | 38,531 | $5.0K | 2023-05-10 |
| 2023-08-08 | S, sale reported on Form 4 | 2,004 | $19.1K | 2023-08-09 |
| 2023-11-02 | S, sale reported on Form 4 | 3,999 | $1.3K | 2023-11-03 |
| 2023-11-08 | S, sale reported on Form 4 | 1,811 | $598 | 2023-11-08 |
Seres Therapeutics, Inc. (MCRB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
EPIX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
GRI Bio, Inc. (VLON)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CNTA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CARM
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1826323) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms